209 related articles for article (PubMed ID: 15245594)
1. Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.
Oji Y; Nakamori S; Fujikawa M; Nakatsuka S; Yokota A; Tatsumi N; Abeno S; Ikeba A; Takashima S; Tsujie M; Yamamoto H; Sakon M; Nezu R; Kawano K; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Oka Y; Yoshikawa K; Aozasa K; Monden M; Sugiyama H
Cancer Sci; 2004 Jul; 95(7):583-7. PubMed ID: 15245594
[TBL] [Abstract][Full Text] [Related]
2. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth.
Kayed H; Kleeff J; Kolb A; Ketterer K; Keleg S; Felix K; Giese T; Penzel R; Zentgraf H; Büchler MW; Korc M; Friess H
Int J Cancer; 2006 Jan; 118(1):43-54. PubMed ID: 16003754
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response.
Takahara A; Koido S; Ito M; Nagasaki E; Sagawa Y; Iwamoto T; Komita H; Ochi T; Fujiwara H; Yasukawa M; Mineno J; Shiku H; Nishida S; Sugiyama H; Tajiri H; Homma S
Cancer Immunol Immunother; 2011 Sep; 60(9):1289-97. PubMed ID: 21607557
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma.
Oji Y; Yamamoto H; Nomura M; Nakano Y; Ikeba A; Nakatsuka S; Abeno S; Kiyotoh E; Jomgeow T; Sekimoto M; Nezu R; Yoshikawa Y; Inoue Y; Hosen N; Kawakami M; Tsuboi A; Oka Y; Ogawa H; Souda S; Aozasa K; Monden M; Sugiyama H
Cancer Sci; 2003 Aug; 94(8):712-7. PubMed ID: 12901797
[TBL] [Abstract][Full Text] [Related]
5. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
[TBL] [Abstract][Full Text] [Related]
6. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
7. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.
Oji Y; Ogawa H; Tamaki H; Oka Y; Tsuboi A; Kim EH; Soma T; Tatekawa T; Kawakami M; Asada M; Kishimoto T; Sugiyama H
Jpn J Cancer Res; 1999 Feb; 90(2):194-204. PubMed ID: 10189890
[TBL] [Abstract][Full Text] [Related]
9. Extremely High Expression of Antisense RNA for Wilms' Tumor 1 in Active Osteoclasts: Suppression of Wilms' Tumor 1 Protein Expression during Osteoclastogenesis.
Li YJ; Kukita A; Kyumoto-Nakamura Y; Kukita T
Am J Pathol; 2016 Sep; 186(9):2317-25. PubMed ID: 27393793
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the Wilms' tumor gene WT1 in esophageal cancer.
Oji Y; Yano M; Nakano Y; Abeno S; Nakatsuka S; Ikeba A; Yasuda T; Fujiwara Y; Takiguchi S; Yamamoto H; Fujita S; Kanato K; Ito K; Jomgeow T; Kawakami M; Tsuboi A; Shirakata T; Nishida S; Hosen N; Oka Y; Aozasa K; Monden M; Sugiyama H
Anticancer Res; 2004; 24(5B):3103-8. PubMed ID: 15510596
[TBL] [Abstract][Full Text] [Related]
11. Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial.
Nagai K; Adachi T; Harada H; Eguchi S; Sugiyama H; Miyazaki Y
Anticancer Res; 2020 Oct; 40(10):5765-5776. PubMed ID: 32988904
[TBL] [Abstract][Full Text] [Related]
12. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
13. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer development and progression: remodeling the model.
Real FX; Cibrián-Uhalte E; Martinelli P
Gastroenterology; 2008 Sep; 135(3):724-8. PubMed ID: 18692502
[No Abstract] [Full Text] [Related]
15. The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas.
Luo X; Yang Z; Liu X; Liu Z; Miao X; Li D; Zou Q; Yuan Y
Tumour Biol; 2017 May; 39(5):1010428317699129. PubMed ID: 28466777
[TBL] [Abstract][Full Text] [Related]
16. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas.
Nakahara Y; Okamoto H; Mineta T; Tabuchi K
Brain Tumor Pathol; 2004; 21(3):113-6. PubMed ID: 15696971
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer.
Koido S; Okamoto M; Shimodaira S; Sugiyama H
Immunotherapy; 2016 Nov; 8(11):1309-1320. PubMed ID: 27993090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
